CVS Stock Recent News
CVS LATEST HEADLINES
A competition probe into Britain's veterinary market is unlikely to hit CVS Group (AIM:CVSG) PLC and Pets at Home Group PLC (LSE:PETS) as hard as feared, analysts have reassured. The Competition and Markets Authority would likely look to enforce more transparency, rather than taking drastic measures such as forcing disposals and capping product prices, Liberum analysts said in a note.
CVS Health (CVS) closed the most recent trading day at $74.60, moving +1.06% from the previous trading session.
Health insurance stocks slid yesterday, after final Medicare Advantage (MA) payment rates fell below expectations.
Zacks Retail-Pharmacies and Drug Stores industry players like CVS and WBA are likely to gain despite reimbursement challenges that are hurting the overall health industry. HLF might face the wrath of economic challenges.
Humana, CVS, and UnitedHealth all fell after the CMS approved a 3.7% payment rate increase for Medicare Advantage plans for 2025. "Core" payments are actually expected to decline slightly after accounting for higher utilization trends.
CNBC's Bertha Coombs reports on what's driving health insurer stocks lower.
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The rate adds more pressure on insurers already grappling with high medical costs and uncertainty after the cyberattack on UnitedHealth Group's tech unit.
Higher costs and lower hikes in rates can lead to lower profit growth, which concerns investors.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.